Novel use of peptide compounds for treating dyskinesia

Details for Australian Patent Application No. 2005244440 (hide)

Owner Schwarz Pharma AG

Inventors Stohr, Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2005244440

PCT Pub. Number WO2005/110390

Priority 60/571,932 18.05.04 US; 04 011 833.3 18.05.04 EP

Filing date 17 May 2005

Wipo publication date 24 November 2005

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110390 Priority application(s): WO2005/110390

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244443-Oil-in-water emulsion for delivery

2005244439-Combinations of glycopyrrolate and beta2 adrenoceptor agonists